Translational Paradigms in Cerebrovascular Gene Transfer

Vini G. Khurana, Fredric B. Meyer

Research output: Contribution to journalReview article

9 Citations (Scopus)

Abstract

Gene transfer involves the use of an engineered biologic vehicle known as a vector to introduce a gene encoding a protein of interest into a particular tissue. In diseases with known defects at a genetic level, gene transfer offers a potential means of restoring a normal molecular environment via vector-mediated entry (transduction) and expression of genes encoding potentially therapeutic proteins selectively in diseased tissues. The technology of gene transfer therefore underlies the concept of gene therapy and falls under the umbrella of the current genomics revolution. Particularly since 1995, numerous attempts have been made to introduce genes into intracranial blood vessels to demonstrate and characterize viable transduction. More recently, in attempting to translate cerebrovascular gene transfer technology closer to the clinical arena, successful transductions of normal human cerebral arteries ex vivo and diseased animal cerebral arteries in vivo have been reported using vasomodulatory vectors. Considering the emerging importance of gene-based strategies for the treatment of the spectrum of human disease, the goals of the present report are to overview the fundamentals of gene transfer and review experimental studies germane to the clinical translation of a technology that can facilitate genetic modification of cerebral blood vessels.

Original languageEnglish (US)
Pages (from-to)1251-1262
Number of pages12
JournalJournal of Cerebral Blood Flow and Metabolism
Volume23
Issue number11
StatePublished - Nov 2003
Externally publishedYes

Fingerprint

Genes
Technology Transfer
Blood Vessels
Cerebral Arterial Diseases
Cerebral Arteries
Genomics
Genetic Therapy
Proteins
Technology
Gene Expression
Therapeutics

Keywords

  • Adenovirus
  • Cerebral vasospasm
  • Gene therapy
  • Nitric oxide
  • Subarachnoid hemorrhage

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Neuroscience(all)

Cite this

Translational Paradigms in Cerebrovascular Gene Transfer. / Khurana, Vini G.; Meyer, Fredric B.

In: Journal of Cerebral Blood Flow and Metabolism, Vol. 23, No. 11, 11.2003, p. 1251-1262.

Research output: Contribution to journalReview article

Khurana, Vini G. ; Meyer, Fredric B. / Translational Paradigms in Cerebrovascular Gene Transfer. In: Journal of Cerebral Blood Flow and Metabolism. 2003 ; Vol. 23, No. 11. pp. 1251-1262.
@article{1f7db0e72d3f411caa717487aa45594a,
title = "Translational Paradigms in Cerebrovascular Gene Transfer",
abstract = "Gene transfer involves the use of an engineered biologic vehicle known as a vector to introduce a gene encoding a protein of interest into a particular tissue. In diseases with known defects at a genetic level, gene transfer offers a potential means of restoring a normal molecular environment via vector-mediated entry (transduction) and expression of genes encoding potentially therapeutic proteins selectively in diseased tissues. The technology of gene transfer therefore underlies the concept of gene therapy and falls under the umbrella of the current genomics revolution. Particularly since 1995, numerous attempts have been made to introduce genes into intracranial blood vessels to demonstrate and characterize viable transduction. More recently, in attempting to translate cerebrovascular gene transfer technology closer to the clinical arena, successful transductions of normal human cerebral arteries ex vivo and diseased animal cerebral arteries in vivo have been reported using vasomodulatory vectors. Considering the emerging importance of gene-based strategies for the treatment of the spectrum of human disease, the goals of the present report are to overview the fundamentals of gene transfer and review experimental studies germane to the clinical translation of a technology that can facilitate genetic modification of cerebral blood vessels.",
keywords = "Adenovirus, Cerebral vasospasm, Gene therapy, Nitric oxide, Subarachnoid hemorrhage",
author = "Khurana, {Vini G.} and Meyer, {Fredric B.}",
year = "2003",
month = "11",
language = "English (US)",
volume = "23",
pages = "1251--1262",
journal = "Journal of Cerebral Blood Flow and Metabolism",
issn = "0271-678X",
publisher = "Nature Publishing Group",
number = "11",

}

TY - JOUR

T1 - Translational Paradigms in Cerebrovascular Gene Transfer

AU - Khurana, Vini G.

AU - Meyer, Fredric B.

PY - 2003/11

Y1 - 2003/11

N2 - Gene transfer involves the use of an engineered biologic vehicle known as a vector to introduce a gene encoding a protein of interest into a particular tissue. In diseases with known defects at a genetic level, gene transfer offers a potential means of restoring a normal molecular environment via vector-mediated entry (transduction) and expression of genes encoding potentially therapeutic proteins selectively in diseased tissues. The technology of gene transfer therefore underlies the concept of gene therapy and falls under the umbrella of the current genomics revolution. Particularly since 1995, numerous attempts have been made to introduce genes into intracranial blood vessels to demonstrate and characterize viable transduction. More recently, in attempting to translate cerebrovascular gene transfer technology closer to the clinical arena, successful transductions of normal human cerebral arteries ex vivo and diseased animal cerebral arteries in vivo have been reported using vasomodulatory vectors. Considering the emerging importance of gene-based strategies for the treatment of the spectrum of human disease, the goals of the present report are to overview the fundamentals of gene transfer and review experimental studies germane to the clinical translation of a technology that can facilitate genetic modification of cerebral blood vessels.

AB - Gene transfer involves the use of an engineered biologic vehicle known as a vector to introduce a gene encoding a protein of interest into a particular tissue. In diseases with known defects at a genetic level, gene transfer offers a potential means of restoring a normal molecular environment via vector-mediated entry (transduction) and expression of genes encoding potentially therapeutic proteins selectively in diseased tissues. The technology of gene transfer therefore underlies the concept of gene therapy and falls under the umbrella of the current genomics revolution. Particularly since 1995, numerous attempts have been made to introduce genes into intracranial blood vessels to demonstrate and characterize viable transduction. More recently, in attempting to translate cerebrovascular gene transfer technology closer to the clinical arena, successful transductions of normal human cerebral arteries ex vivo and diseased animal cerebral arteries in vivo have been reported using vasomodulatory vectors. Considering the emerging importance of gene-based strategies for the treatment of the spectrum of human disease, the goals of the present report are to overview the fundamentals of gene transfer and review experimental studies germane to the clinical translation of a technology that can facilitate genetic modification of cerebral blood vessels.

KW - Adenovirus

KW - Cerebral vasospasm

KW - Gene therapy

KW - Nitric oxide

KW - Subarachnoid hemorrhage

UR - http://www.scopus.com/inward/record.url?scp=0242658592&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0242658592&partnerID=8YFLogxK

M3 - Review article

C2 - 14600432

AN - SCOPUS:0242658592

VL - 23

SP - 1251

EP - 1262

JO - Journal of Cerebral Blood Flow and Metabolism

JF - Journal of Cerebral Blood Flow and Metabolism

SN - 0271-678X

IS - 11

ER -